Indaptus Therapeutics Extends $24M Private Placement Outside Date to Oct 16

Indaptus Therapeutics, Inc. announced an extension of the outside date for its previously disclosed $24.0 million private placement of common stock. The original outside date was September 29, 2026, and has now been extended to October 16, 2026. The company and the purchasers have entered into notices and consents that allow for the deferral and coordination of the closing until applicable conditions are met, but no later than the extended outside date. The purchase agreement itself remains unchanged and in full force and effect.